UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Editorial to the Special Issue "Activations of Cadherin Signaling in Cancer"

International journal of molecular sciences, 2022-06, Vol.23 (13), p.7022

Tomassetti, Antonella

2022

Volltextzugriff (PDF)

One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer

International journal of molecular sciences, 2018-07, Vol.19 (7), p.2092

2018

Volltextzugriff (PDF)

Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells

International journal of molecular sciences, 2016-08, Vol.17 (9), p.1387-1387

2016

Volltextzugriff (PDF)

Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer

Frontiers in oncology, 2022-07, Vol.12, p.923508-923508

2022

Volltextzugriff (PDF)

Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells

Journal of experimental & clinical cancer research, 2021-01, Vol.40 (1), p.5-5, Article 5

2021

Volltextzugriff (PDF)

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth

Journal of experimental & clinical cancer research, 2018-07, Vol.37 (1), p.146-146, Article 146

2018

Volltextzugriff (PDF)

Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial

Journal of experimental & clinical cancer research, 2023-04, Vol.42 (1), p.83-83, Article 83

2023

Volltextzugriff (PDF)

Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions

Organic & biomolecular chemistry, 2015-03, Vol.13 (9), p.2570-2573

2015

Volltextzugriff (PDF)

Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells

Experimental cell research, 2007-04, Vol.313 (7), p.1307-1317

2007

Volltextzugriff (PDF)

Simultaneous Expression of Caveolin-1 and E-Cadherin in Ovarian Carcinoma Cells Stabilizes Adherens Junctions through Inhibition of src-Related Kinases

The American journal of pathology, 2005-11, Vol.167 (5), p.1411-1427

2005

Volltextzugriff (PDF)

Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas

PloS one, 2010-09, Vol.5 (9), p.e12701-e12701

2010

Volltextzugriff (PDF)

New potential ligand-receptor signaling loops in ovarian cancer identified in multiple gene expression studies

Cancer research (Chicago, Ill.), 2006-11, Vol.66 (22), p.10709-10719

2006

Volltextzugriff (PDF)

Reduced sulfatide content in deferoxamine-induced senescent HepG2 cells

The international journal of biochemistry & cell biology, 2023-06, Vol.159, p.106419-106419, Article 106419

2023

Volltextzugriff (PDF)

Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to α-folate receptor overexpression

Oncogene, 2000-09, Vol.19 (41), p.4754-4763

2000

Volltextzugriff (PDF)

Variant HNF1 Modulates Epithelial Plasticity of Normal and Transformed Ovary Cells

Neoplasia (New York, N.Y.), 2008-12, Vol.10 (12), p.1481,IN12-1492,IN14

2008

Volltextzugriff (PDF)

Human Cutaneous Melanomas Lacking MITF and Melanocyte Differentiation Antigens Express a Functional Axl Receptor Kinase

Journal of investigative dermatology, 2011-12, Vol.131 (12), p.2448-2457

2011

Volltextzugriff (PDF)

Axl in ovarian cancer: a step forward for clinical breakthrough?

Oncotarget, 2016-12, Vol.7 (49), p.80105-80106

2016

Volltextzugriff (PDF)

Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment

European journal of cancer (1990), 2022-01, Vol.161, p.55-63

2022

Volltextzugriff (PDF)

Crystal Structure of Human E‑Cadherin-EC1EC2 in Complex with a Peptidomimetic Competitive Inhibitor of Cadherin Homophilic Interaction

Journal of medicinal chemistry, 2016-05, Vol.59 (10), p.5089-5094

2016

Volltextzugriff (PDF)

Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer Patients

Anticancer research, 2016-08, Vol.36 (8), p.4155-4163

2016

Volltextzugriff (PDF)

Abstract A39: An integrated molecular and metabolic approach for harnessing early relapse and chemoresistance in ovarian cancer

Clinical cancer research, 2018-08, Vol.24 (15_Supplement), p.A39-A39

2018

Volltextzugriff (PDF)

An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response

BMC genomics, 2013-07, Vol.14 (1), p.508-508, Article 508

2013

Volltextzugriff (PDF)

Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome

Oncotarget, 2015-10, Vol.6 (31), p.30859-30875

2015

Volltextzugriff (PDF)

A Cell-Autonomous Oncosuppressive Role of Human RNASET2 Affecting ECM-Mediated Oncogenic Signaling

Cancers, 2019-02, Vol.11 (2), p.255

2019

Volltextzugriff (PDF)

Abstract A76: EGFR activation signaling cascade leads to phosphorylation on serine 732 of FAK and mitosis in a subset of epithelial ovarian cancer

Clinical cancer research, 2013-10, Vol.19 (19_Supplement), p.A76-A76

2013

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(74)
Buchkapitel
(1)

Sprache

Englisch
(75)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Editorial to the Special Issue "Activations of Cadherin Signaling in Cancer"

One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer

Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells

Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer

Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth

Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial

Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions

Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells

Simultaneous Expression of Caveolin-1 and E-Cadherin in Ovarian Carcinoma Cells Stabilizes Adherens Junctions through Inhibition of src-Related Kinases

Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas

New potential ligand-receptor signaling loops in ovarian cancer identified in multiple gene expression studies

Reduced sulfatide content in deferoxamine-induced senescent HepG2 cells

Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to α-folate receptor overexpression

Variant HNF1 Modulates Epithelial Plasticity of Normal and Transformed Ovary Cells

Human Cutaneous Melanomas Lacking MITF and Melanocyte Differentiation Antigens Express a Functional Axl Receptor Kinase

Axl in ovarian cancer: a step forward for clinical breakthrough?

Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment

Crystal Structure of Human E‑Cadherin-EC1EC2 in Complex with a Peptidomimetic Competitive Inhibitor of Cadherin Homophilic Interaction

Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer Patients

Abstract A39: An integrated molecular and metabolic approach for harnessing early relapse and chemoresistance in ovarian cancer

An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response

Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome

A Cell-Autonomous Oncosuppressive Role of Human RNASET2 Affecting ECM-Mediated Oncogenic Signaling

Abstract A76: EGFR activation signaling cascade leads to phosphorylation on serine 732 of FAK and mitosis in a subset of epithelial ovarian cancer

Suchergebnisse filtern